Back to ARK Investment Management LLC ARK Investment Management LLC

ENLVENLV
11 quarters

Position history for ARK Investment Management LLCARK Investment Management LLC's holdings in ENLIVEX THERAPEUTICS LTD

Yes. ARK Investment Management holds 2,382,731 shares of ENLV (Enlivex Therapeutics), worth $1.3M, as of its Q2 2026 13F filing. It increased the position from 628,310 shares in Q1 2026. ARK Investment Management has held ENLV since Q1 2026, across 2 quarterly 13F filings.

Current Value

$1.3M

Current Shares

2.4M

Total Value Change

+$987,264

Total Shares Change

+2.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.4M
+279.2%
$1.3M0.0%$131.98
41
2026-Q1
New
628,310
-
$584,3910.0%$223.22
34
2022-Q3
Exited
0
-100.0%
$00.0%$1,020.00
0
2022-Q2
Decreased
331,001
-23.8%
$1.7M0.0%$1,084.80
0
2022-Q1
Increased
434,343
+24.3%
$2.4M0.0%$1,341.60
32
2021-Q4
Decreased
349,308
-23.7%
$2.2M0.0%$1,500.00
0
2021-Q3
Decreased
457,797
-11.1%
$4.5M0.0%$2,371.20
0
2021-Q2
Increased
514,807
+8.1%
$4.6M0.0%$2,136.00
29
2021-Q1
New
476,414
-
$5.3M0.0%$2,661.60
37
2020-Q1
Exited
0
-100.0%
$00.0%$1,123.20
0
2019-Q4
New
38,536
-
$323,0000.0%$2,013.94
33

Other major holders of ENLV: RENAISSANCE TECHNOLOGIES LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used